Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease

Endothelial dysfunction is considered to be the first step in atherogenesis as well as a predictor of adverse cardiovascular events in patients with coronary artery disease (CAD), while endothelial function improvement is associated with improved clinical outcome. Nebivolol is a beta1-adrenoreceptor...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cardiovascular drugs and therapy 2005-08, Vol.19 (4), p.277-281
Hauptverfasser:	LEKAKIS, John P, PROTOGEROU, Athanassios, PAPAMICHAEL, Christos, VAMVAKOU, Georgia, ICONOMIDIS, Ignatios, FICI, Francesco, MAVRIKAKIS, Myron
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Antagonists - therapeutic use Aged Atenolol - therapeutic use Benzopyrans - therapeutic use Biological and medical sciences Brachial Artery - drug effects Brachial Artery - physiopathology Cardiology. Vascular system Cardiovascular system Coronary Artery Disease - drug therapy Coronary Artery Disease - physiopathology Coronary heart disease Endothelium, Vascular - drug effects Endothelium, Vascular - physiopathology Ethanolamines - therapeutic use Heart Humans Male Medical sciences Middle Aged Nebivolol Pharmacology. Drug treatments Vasodilation - drug effects Vasodilator Agents - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!